雜志介紹

Journal Of Immunotherapy雜志介紹

《Journal Of Immunotherapy》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱免疫療法雜志，本刊主要出版、報道醫(yī)學-IMMUNOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為3.2，最新CiteScore 指數(shù)為6.9。

本刊近期中國學者發(fā)表的論文主要有：

• Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.

  Author: Liu J, Zhang S, Hu Y, Yang Z, Li J, Liu X, Deng L, Wang Y, Zhang X, Jiang T, Lu X.

• The Distribution of Human Stem Cell-like Memory T Cell in Lung Cancer.

  Author: Hong H, Gu Y, Sheng SY, Lu CG, Zou JY, Wu CY.

• Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling.

  Author: Bie N, Zhao X, Li Z, Qi G.

• Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma.

  Author: Li JJ, Gu MF, Pan K, Liu LZ, Zhang H, Shen WX, Xia JC.

英文介紹

Journal Of Immunotherapy雜志英文介紹

Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.